Pip Nicolson/X
Jun 6, 2025, 10:56
Pip Nicolson Highlights Key PITT Case Insight on Anti-PF4 Antibody Testing
Pip Nicolson, Associate Clinical Professor in Cardiovascular Medicine (Haematology) at University of Birmingham, shared on X:
“Thank you Prof. Makris for your clear and concise commentary on our PITT case in the British Journal of Hematology.
Take home message: test anyone with the combination of thrombosis and thrombocytopenia for anti-PF4 antibodies (by ELISA) and have a low threshold for starting non-heparin anticoagulation.”
You Can Find More Posts Featuring Pip Nicolson on Hemostasis Today.
Title: PF4-associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines
Author: Michael Makris
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice